ImmuPharma PLC (UK) Analysis
| IMM Stock | 1.43 0.04 2.72% |
ImmuPharma PLC is overvalued with Real Value of 1.31 and Hype Value of 1.43. The main objective of ImmuPharma PLC stock analysis is to determine its intrinsic value, which is an estimate of what ImmuPharma PLC is worth, separate from its market price. There are two main types of ImmuPharma PLC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ImmuPharma PLC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ImmuPharma PLC's stock to identify patterns and trends that may indicate its future price movements.
The ImmuPharma PLC stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ImmuPharma PLC's ongoing operational relationships across important fundamental and technical indicators.
ImmuPharma |
ImmuPharma Stock Analysis Notes
About 48.0% of the company shares are held by company insiders. The book value of ImmuPharma PLC was currently reported as 0.01. The company recorded a loss per share of 0.01. ImmuPharma PLC last dividend was issued on the 14th of December 2021. The entity had 1:1 split on the 17th of August 2022. To learn more about ImmuPharma PLC call XIV FCCA at 44 20 7206 2650 or check out https://www.immupharma.co.uk.ImmuPharma PLC Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ImmuPharma PLC's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ImmuPharma PLC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ImmuPharma PLC may become a speculative penny stock | |
| ImmuPharma PLC had very high historical volatility over the last 90 days | |
| ImmuPharma PLC has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.92 M) with profit before overhead, payroll, taxes, and interest of 118.35 K. | |
| ImmuPharma PLC generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
ImmuPharma Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ImmuPharma PLC's market, we take the total number of its shares issued and multiply it by ImmuPharma PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
ImmuPharma PLC has return on total asset (ROA) of (0.43) % which means that it has lost $0.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.112) %, meaning that it generated substantial loss on money invested by shareholders. ImmuPharma PLC's management efficiency ratios could be used to measure how well ImmuPharma PLC manages its routine affairs as well as how well it operates its assets and liabilities. At present, ImmuPharma PLC's Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 5.2 M, whereas Non Current Assets Total are forecasted to decline to about 1.4 M.The decision-making processes within ImmuPharma PLC are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin 36.1472 | Beta 1.581 | Return On Assets (0.43) | Return On Equity (1.11) |
Technical Drivers
As of the 29th of November, ImmuPharma PLC retains the Risk Adjusted Performance of 0.0218, downside deviation of 3.98, and Market Risk Adjusted Performance of 0.1373. ImmuPharma PLC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out ImmuPharma PLC maximum drawdown, semi variance, and the relationship between the jensen alpha and potential upside to decide if ImmuPharma PLC is priced fairly, providing market reflects its last-minute price of 1.43 per share.ImmuPharma PLC Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ImmuPharma PLC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ImmuPharma PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
ImmuPharma PLC Outstanding Bonds
ImmuPharma PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ImmuPharma PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ImmuPharma bonds can be classified according to their maturity, which is the date when ImmuPharma PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
ImmuPharma PLC Predictive Daily Indicators
ImmuPharma PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ImmuPharma PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 186135.0 | |||
| Daily Balance Of Power | (0.19) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.52 | |||
| Day Typical Price | 1.49 | |||
| Price Action Indicator | (0.11) | |||
| Period Momentum Indicator | (0.04) |
ImmuPharma PLC Forecast Models
ImmuPharma PLC's time-series forecasting models are one of many ImmuPharma PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ImmuPharma PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ImmuPharma Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ImmuPharma PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ImmuPharma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ImmuPharma PLC. By using and applying ImmuPharma Stock analysis, traders can create a robust methodology for identifying ImmuPharma entry and exit points for their positions.
ImmuPharma PLC is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ImmuPharma PLC to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Complementary Tools for ImmuPharma Stock analysis
When running ImmuPharma PLC's price analysis, check to measure ImmuPharma PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuPharma PLC is operating at the current time. Most of ImmuPharma PLC's value examination focuses on studying past and present price action to predict the probability of ImmuPharma PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuPharma PLC's price. Additionally, you may evaluate how the addition of ImmuPharma PLC to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |